Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept Injection Methods in Severe Proliferative Diabetic Retinopathy
NCT02816710Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Jul 2016
- Primary completion
- Sep 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of conbercept in proliferative diabetic retinopathy (PDR), sponsored by Ruijin Hospital. Started Jul 2016; status: completed.
02
Drugs
conbercept
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT02816710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02816710.